Two Sigma Investments, LP Coherus Bio Sciences, Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 134,138 shares of CHRS stock, worth $144,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares

134,138

Previous 682,380 80.34%

Holding current value

$144,869

Previous $709,000 73.91%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.67 - $1.71 $367,322 - $937,493	-548,242 Reduced 80.34%	134,138 $185,000
Q3 2024 Nov 14, 2024	SELL	$0.99 - $1.8 $150,342 - $273,349	-151,861 Reduced 18.2%	682,380 $709,000
Q2 2024 Aug 14, 2024	SELL	$1.58 - $2.51 $991,879 - $1.58 Million	-627,772 Reduced 42.94%	834,241 $1.44 Million
Q1 2024 May 15, 2024	BUY	$2.02 - $3.14 $23,555 - $36,615	11,661 Added 0.8%	1,462,013 $3.49 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $2.31 Million - $5.58 Million	1,450,352 New	1,450,352 $4.83 Million
Q1 2023 May 15, 2023	SELL	$5.89 - $10.52 $569,969 - $1.02 Million	-96,769 Reduced 80.73%	23,100 $158,000
Q4 2022 Feb 14, 2023	SELL	$5.69 - $10.07 $1.42 Million - $2.52 Million	-249,914 Reduced 67.58%	119,869 $949,000
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $2.52 Million - $4.87 Million	351,205 Added 1890.43%	369,783 $3.55 Million
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $108,867 - $245,786	18,578 New	18,578 $135,000
Q1 2022 May 16, 2022	SELL	$10.92 - $16.41 $170,352 - $255,996	-15,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $246,636 - $296,244	15,600 New	15,600 $249,000
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $1.27 Million - $1.51 Million	-98,160 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $1.42 Million - $2.1 Million	98,160 New	98,160 $1.43 Million
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $2.27 Million - $3.02 Million	-157,591 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $5.79 Million - $11.2 Million	-496,281 Reduced 75.9%	157,591 $2.56 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $9.2 Million - $12 Million	563,679 Added 624.97%	653,872 $11.8 Million
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $1.14 Million - $1.63 Million	-69,666 Reduced 43.58%	90,193 $1.83 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $1.54 Million - $2.6 Million	117,712 Added 279.29%	159,859 $3.53 Million
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $1.61 Million - $2.98 Million	-191,958 Reduced 82.0%	42,147 $575,000
Q4 2018 Feb 14, 2019	BUY	$8.65 - $16.28 $646,068 - $1.22 Million	74,690 Added 46.85%	234,105 $2.12 Million
Q3 2018 Nov 14, 2018	SELL	$14.45 - $20.25 $2.53 Million - $3.55 Million	-175,072 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$10.25 - $17.45 $1.79 Million - $3.06 Million	175,072 New	175,072 $2.45 Million

Others Institutions Holding CHRS

# of Institutions

130

Shares Held

67.8M

Call Options Held

1.68M

Put Options Held

91.8K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $83.9M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Coherus Bio Sciences, Inc. Transaction History